Investigators discuss the current state of non-alcoholic fatty liver disease metabolites, gut micro-environmental changes, and the further challenges in digital metabolomics profiling.
[Clinica Chimica Acta]
7992332
{7992332:CCCCCCCC}
apa
50
1
168012
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
